AMNEAL AND INDOCO PARTNER TO MAKE GENERIC OPHTHALMICS

JANUARY 01, 2008

A new generic-industry joint venture linking New Jersey?based Amneal Pharmaceuticals and India?s Indoco Remedies will result in the marketing of at least 10 generic ophthalmic products in the United States.

Amneal?s role in the partnership will be to prepare and file abbreviated new drug applications for FDA approval and to exclusively market these products throughout the US pharmaceutical market. Indoco will be responsible for manufacturing the generics. Spokesmen for the 2 companies said that Indoco and Amneal have already begun to identify several more ophthalmic products to pursue, as well as other therapeutic categories and dosage forms.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.